Beantown Biotech Competitors and Similar CompaniesClear all

Beantown Biotech's competitors and similar companies include Inflazome, Quanterix and Genfit.

	Beantown Biotech Beantown Biotech is a contract drug discovery research company.	Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.	Quanterix Quanterix is a platform for single molecule analysis that supports clinical diagnostics, drug development, and life science researches.	Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
Founding Date	Founding Date 2012	Founding Date 2016	Founding Date 2007	Founding Date 1999
Type	Type Private	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech contractor drug development medical diagnostics	Tags Healthcare biotech drug development medical diagnostics	Tags Healthcare biotech drug development life sciences medical diagnostics	Tags Healthcare biotech drug development medical diagnostics pharma
Locations	Locations Natick, US HQ	Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB	Locations Billerica, US HQ Baltimore, US Philadelphia, US San Diego, US San Francisco, US Seattle, US	Locations Loos, FR HQ Cambridge, US
Employees	Employees 137% decrease	Employees 156% decrease	Employees 24840% increase	Employees 180
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 506.2 m	Valuation ($) 280.8 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $138.9m (FY, 2025)	Revenue (est.) €65.4m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $73.9m (FY, 2025)	Cost of goods €302k (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $65m (FY, 2025)	Gross profit €70.8m (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income ($107.2m) (FY, 2025)	Net income (€86m) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 17m	Total funding raised $ 96.5m	Total funding raised N/A